Clinical trial

Combined Vasopressin, Methylprednisolone, and Epinephrine for Inhospital Cardiac…

NCT00411879 · University of Athens, Other · Completed

Key facts

NCT number NCT00411879
Title Combined Vasopressin, Methylprednisolone, and Epinephrine for Inhospital Cardiac Arrest
Official title Phase 2, Single-Center, Placebo-Controlled Study of the Effects of Combined Administration of Vasopressin, Methylprednisolone, and Epinephrine During Cardiopulmonary Resuscitation on Survival After Cardiac Arrest
Lead sponsor University of Athens, Other
Status Completed
Phase Phase 2
Study type Interventional
Conditions Heart Arrest
Intervention type Drug
Interventions Vasopressin, Epinephrine, and Steroids, Placebo
Enrollment 100
Start date Jun 1, 2006
Primary completion Apr 1, 2007
Completion Apr 1, 2007
First posted Dec 15, 2006
Last update posted Jan 12, 2016
Countries Greece

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies